Larvol Delta - SIERRA1-Study-to-Evaluate-Soquelitinib-in-Participants-With-Moderate-to-Severe-AD

soquelitinib (CPI-818) - Corvus Pharma

http://clinicaltrials.gov/ct2/show/NCT07441395

Mar 6, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next